MFT lupus patient first recruit to NIHR IMID BioResource
A lupus patient at the Manchester Royal Infirmary (MRI) was the first UK recruit to the newly launched NIHR IMID BioResource.
Read moreA lupus patient at the Manchester Royal Infirmary (MRI) was the first UK recruit to the newly launched NIHR IMID BioResource.
Read moreA decade-long study has identified the factor produced by a common species of skin bacteria that triggers eczema.
Read moreA drug has shown potential to improve heart function in women diagnosed with preeclampsia during their pregnancy, research carried out at Saint Mary’s Hospital has found.
Read moreThe first UK patient has been treated in new COVID-19 research trialling the impact of an experimental arthritis drug, otilimab, on severe lung disease related to COVID-19.
Read moreThe third chapter of a nine-part webcomic, Planet DIVOC-91, featuring articles and art by young adults about COVID-19, was recently published.
Read moreManchester University NHS Foundation Trust’s (MFT) ground-breaking qUEST research, part of the Manchester Lung Health Checks programme, has been named among the top-recruiting cancer studies in Englan
Read moreManchester doctors have played a leading role in global coronavirus research, which has found the first drug shown to increase survival rates in people hospitalised with COVID-19.
Read more